One of today's stocks on the move is AMAG Pharmaceuticals (NASDAQ:AMAG), up 1.9% to $22.25. The S&P is trading higher by 0.5% to 1,554 and the Dow is trading 0.5% higher to 14,494.
AMAG Pharmaceuticals (NASDAQ:AMAG) is currently priced 23.6% above its average consensus analyst price target of $17.00. The stock should discover initial support at its 50-day moving average (MA) of $17.18 and subsequent support at its 200-day MA of $15.98.
Over the past year, AMAG Pharmaceuticals has traded in a range of $12.43 to $22.75 and is now at $22.25, 79% above that low. Over the last five market days, the 200-day moving average (MA) has gone up 1.0% while the 50-day MA has advanced 2.9%.
AMAG Pharmaceuticals, Inc., a biopharmaceutical company, utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.